Analysis of oxidative stress expressed by urinary level of 8-hydroxy-2′-deoxyguanosine and biopyrrin in atrial fibrillation: Effect of sinus rhythm restoration

International Journal of Cardiology

Volumn 168, Issue 1, 2013, Pages 80-85

  Toyama, Kensuke ^a   Yamabe, Hiroshige ^a   Uemura, Takashi ^a   Nagayoshi, Yasuhiro ^a   Morihisa, Kenji ^a   Koyama, Junjiroh ^a   Kanazawa, Hisanori ^a   Hoshiyama, Tadashi ^a   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

8 Hydroxy 2 deoxyguanosine; Atrial fibrillation; Biopyrrins; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILIRUBIN; BIOLOGICAL MARKER; BIOPYRRIN; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CARDIOVERSION; CATHETER; CATHETER ABLATION; CHRONIC DISEASE; CONTROLLED STUDY; DNA DAMAGE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; SINUS RHYTHM; SINUS RHYTHM RESTORATION; URINE LEVEL;

8-HYDROXY-2′-DEOXYGUANOSINE; 8-OHDG; ACE-I; AF; ANGIOTENSIN CONVERTING ENZYME INHIBITOR; ANGIOTENSIN II RECEPTOR BLOCKER; ARB; ATRIAL FIBRILLATION; BIOPYRRINS; BNP; BRAIN NATRIURETIC PEPTIDE; CR; CREATININE; DEOXYRIBONUCLEIC ACID; DNA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; ROS;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BILIRUBIN; BIOLOGICAL MARKERS; DEOXYGUANOSINE; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; TREATMENT OUTCOME;

EID: 84883764554     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.068     Document Type: Article

References (41)

1. W.M. Feinberg, J.L. Blackshear, A. Laupacis, R. Kronmal, and R.G. Hart Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications Arch Intern Med 155 1995 469 473
2. M. Allessie, J. Ausma, and U. Schotten Electrical, contractile and structural remodeling during atrial fibrillation Cardiovasc Res 54 2002 230 246
3. A. Shiroshita-Takeshita, B.J. Brundel, and S. Nattel Atrial fibrillation: basic mechanisms, remodeling and triggers J Interv Card Electrophysiol 13 2005 181 193
4. S. Nattel Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management? Cardiovasc Res 54 2002 347 360
5. M.J. Mihm, F. Yu, and C.A. Carnes Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation Circulation 104 2001 174 180
6. H. Cai, Z. Li, and A. Goette Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke Circulation 106 2002 2854 2858
7. P.H. Lin, S.H. Lee, C.P. Su, and Y.H. Wei Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation Free Radic Biol Med 35 2003 1310 1318
8. Y.M. Kim, T.J. Guzik, and Y.H. Zhang A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation Circ Res 97 2005 629 636
9. S.C. Dudley Jr., N.E. Hoch, and L.A. McCann Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases Circulation 112 2005 1266 1273
10. H. Kasai, and S. Nishimura Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents Nucleic Acids Res 12 1984 2137 2145
11. H. Wiseman, and B. Halliwell Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer Biochem J 313 Pt 1 1996 17 29
12. M.K. Shigenaga, C.J. Gimeno, and B.N. Ames Urinary 8-hydroxy-2′- deoxyguanosine as a biological marker of in vivo oxidative DNA damage Proc Natl Acad Sci U S A 86 1989 9697 9701
13. R. Stocker Antioxidant activities of bile pigments Antioxid Redox Signal 6 2004 841 849
14. T. Morita Heme oxygenase and atherosclerosis Arterioscler Thromb Vasc Biol 25 2005 1786 1795
15. R. Stocker Induction of haem oxygenase as a defence against oxidative stress Free Radic Res Commun 9 1990 101 112
16. P.A. Dennery, A.F. McDonagh, D.R. Spitz, P.A. Rodgers, and D.K. Stevenson Hyperbilirubinemia results in reduced oxidative injury in neonatal Gunn rats exposed to hyperoxia Free Radic Biol Med 19 1995 395 404
17. P.N. Hopkins, L.L. Wu, S.C. Hunt, B.C. James, G.M. Vincent, and R.R. Williams Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease Arterioscler Thromb Vasc Biol 16 1996 250 255
18. S. Shimizu, Y. Izumi, M. Yamazaki, K. Shimizu, T. Yamaguchi, and H. Nakajima Anti-bilirubin monoclonal antibody. I. Preparation and properties of monoclonal antibodies to covalently coupled bilirubin-albumin Biochim Biophys Acta 967 1988 255 260
19. T. Yamaguchi, I. Shioji, A. Sugimoto, Y. Komoda, and H. Nakajima Chemical structure of a new family of bile pigments from human urine J Biochem 116 1994 298 303
20. E. Braunwald Biomarkers in heart failure N Engl J Med 358 2008 2148 2159
21. H. Shimomura, H. Ogawa, and K. Takazoe Comparison of urinary biopyrrin levels in acute myocardial infarction (after reperfusion therapy) versus stable angina pectoris and their usefulness in predicting subsequent cardiac events Am J Cardiol 90 2002 108 111
22. J. Hokamaki, H. Kawano, and M. Yoshimura Urinary biopyrrins levels are elevated in relation to severity of heart failure J Am Coll Cardiol 43 2004 1880 1885
23. Y. Nagayoshi, H. Kawano, and J. Hokamaki Urinary 8-hydroxy-2′- deoxyguanosine levels increase after reperfusion in acute myocardial infarction and may predict subsequent cardiac events Am J Cardiol 95 2005 514 517
24. F. Xiang, X. Shuanglun, and W. Jingfeng Association of serum 8-hydroxy-2′-deoxyguanosine levels with the presence and severity of coronary artery disease Coron Artery Dis 22 2011 223 227
25. S. Kobayashi, T. Susa, and T. Tanaka Urinary 8-hydroxy-2′- deoxyguanosine reflects symptomatic status and severity of systolic dysfunction in patients with chronic heart failure Eur J Heart Fail 13 2011 29 36
26. V. Fuster, L.E. Ryden, and D.S. Cannom ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 123 2011 e269 e367
27. J.I. Choi, S.M. Park, and J.S. Park Changes in left atrial structure and function after catheter ablation and electrical cardioversion for atrial fibrillation Circ J 72 2008 2051 2057
28. R.A. Floyd, J.J. Watson, P.K. Wong, D.H. Altmiller, and R.C. Rickard Hydroxyl free radical adduct of deoxyguanosine: sensitive detection and mechanisms of formation Free Radic Res Commun 1 1986 163 172
29. R.H. Wong, C.Y. Yeh, Y.M. Hsueh, J.D. Wang, Y.C. Lei, and T.J. Cheng Association of hepatitis virus infection, alcohol consumption and plasma vitamin A levels with urinary 8-hydroxydeoxyguanosine in chemical workers Mutat Res 535 2003 181 186
30. C.C. Chiou, P.Y. Chang, E.C. Chan, T.L. Wu, K.C. Tsao, and J.T. Wu Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers Clin Chim Acta 334 2003 87 94
31. C.S. Lin, and C.H. Pan Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation Cell Mol Life Sci 65 2008 1489 1508
32. P. Korantzopoulos, T.M. Kolettis, D. Galaris, and J.A. Goudevenos The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation Int J Cardiol 115 2007 135 143
33. M.C. Wijffels, C.J. Kirchhof, R. Dorland, and M.A. Allessie Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats Circulation 92 1995 1954 1968
34. Y.H. Kim, D.S. Lim, and J.H. Lee Gene expression profiling of oxidative stress on atrial fibrillation in humans Exp Mol Med 35 2003 336 349
35. P. Korantzopoulos, D. Galaris, D. Papaioannides, and S. Kokkoris C-reactive protein and oxidative stress in atrial fibrillation Int J Cardiol 88 2003 103 104
36. M.K. Chung, D.O. Martin, and D. Sprecher C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation Circulation 104 2001 2886 2891
37. J. Dernellis, and M. Panaretou C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation Acta Cardiol 56 2001 375 380
38. V.E. Hagens, D.J. Van Veldhuisen, and O. Kamp Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study Heart Rhythm 2 2005 19 24
39. P. Reant, S. Lafitte, and P. Jais Reverse remodeling of the left cardiac chambers after catheter ablation after 1 year in a series of patients with isolated atrial fibrillation Circulation 112 2005 2896 2903
40. P. Sanders, J.B. Morton, P.M. Kistler, J.K. Vohra, J.M. Kalman, and P.B. Sparks Reversal of atrial mechanical dysfunction after cardioversion of atrial fibrillation: implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy Circulation 108 2003 1976 1984
41. P. Jais, J.T. Peng, and D.C. Shah Left ventricular diastolic dysfunction in patients with so-called lone atrial fibrillation J Cardiovasc Electrophysiol 11 2000 623 625